Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Patients With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 04 May 2016
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 02 May 2016 Status changed from recruiting to completed.
- 14 Oct 2014 Status changed from 'not yet recruiting' to 'recruiting' as reported by ClinicalTrials.gov record.